atropine has been researched along with dexloxiglumide in 4 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (dexloxiglumide) | Trials (dexloxiglumide) | Recent Studies (post-2010) (dexloxiglumide) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 35 | 11 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
André, S; Beglinger, C; Gabius, HJ; Herzig, KH; Hildebrand, P; Ketterer, S; Matzinger, D; Purhonen, AK | 1 |
1 trial(s) available for atropine and dexloxiglumide
Article | Year |
---|---|
Duodenal phytohaemagglutinin (red kidney bean lectin) stimulates gallbladder contraction in humans.
Topics: Adult; Atropine; Cholecystokinin; Cross-Over Studies; Dose-Response Relationship, Drug; Duodenum; Gallbladder; Gallbladder Emptying; Humans; Infusions, Parenteral; Male; Muscarinic Antagonists; Pentanoic Acids; Phytohemagglutinins; Receptors, Cholecystokinin; Receptors, Muscarinic; Single-Blind Method; Ultrasonography | 2008 |
3 other study(ies) available for atropine and dexloxiglumide
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |